The currently proposed study aims to address several of these key knowledge gaps with the following two primary objectives: (1) to systematically compare ablative therapy versus intensive observation alone in outcomes relating to high-grade anal dysplasia; and (2) to better define evidence-based criteria for anal cancer screening using both anal cytology and HPV testing through the validation of an algorithm.